Skip to content
← All treatment topics

TREATMENT READING

Salivary Gland Cancer

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

37 sections
  1. Treatment management
  2. Follow-up after treatment
  3. Treatment Option Overview for Salivary Gland Cancer
  4. Treatment of Stage I Major Salivary Gland Cancer
  5. Treatment Options for Low-Grade Stage I Major Salivary Gland Tumors
  6. Treatment Options for High-Grade Stage I Major Salivary Gland Tumors
  7. Treatment of Stage II Major Salivary Gland Cancer
  8. Treatment Options for Low-Grade Stage II Major Salivary Gland Tumors
  9. Treatment Options for High-Grade Stage II Major Salivary Gland Tumors
  10. Treatment of Stage III Major Salivary Gland Cancer
  11. Treatment Options for Low-Grade Stage III Major Salivary Gland Tumors
  12. Treatment Options for High-Grade Stage III Major Salivary Gland Tumors
  13. Treatment of Stage IV Major Salivary Gland Cancer
  14. Treatment Options for Stage IV Major Salivary Gland Tumors
  15. Fluorouracil dosing
  16. Treatment of Recurrent Major Salivary Gland Cancer
  17. Certain factors affect prognosis (chance of recovery) and treatment options.
  18. Salivary gland cancer can recur (come back) after it has been treated.
  19. Treatment Option Overview
  20. Key Points
  21. There are different types of treatment for patients with salivary gland cancer.
  22. Patients with salivary gland cancer should have their treatment planned by a team of health care providers who are experts in treating head and neck cancer.
  23. The following types of treatment are used:
  24. Surgery
  25. Radiation therapy
  26. Chemotherapy
  27. New types of treatment are being tested in clinical trials.
  28. Radiosensitizers
  29. Treatment for salivary gland cancer may cause side effects.
  30. Patients may want to think about taking part in a clinical trial.
  31. Patients can enter clinical trials before, during, or after starting their cancer treatment.
  32. Follow-up tests may be needed.
  33. Treatment of Stage I Salivary Gland Cancer
  34. Treatment of Stage II Salivary Gland Cancer
  35. Treatment of Stage III Salivary Gland Cancer
  36. Treatment of Stages IVA, IVB, and IVC Salivary Gland Cancer
  37. Treatment of Recurrent Salivary Gland Cancer

Health professional · General Information About Salivary Gland Cancer / Follow-Up and Survivorship

Treatment management

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Perineural invasion can occur, particularly in high-grade adenoid cystic carcinoma, and should be specifically identified and treated.[20] Radiation therapy may increase the chance of local control and increase the survival of patients when adequate margins cannot be achieved.[21][Level of evidence C2] Unresectable or recurrent tumors may respond to chemotherapy.[22-24] Fast neutron-beam radiation therapy or accelerated hyperfractionated photon-beam schedules have been effective in the treatment of inoperable, unresectable, and recurrent tumors.[25-27]

Sources: 20 · 21 · Level of evidence C2 · 22 · 24 · 25 · 27

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional · General Information About Salivary Gland Cancer / Follow-Up and Survivorship

Follow-up after treatment

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Complications of surgical treatment for parotid neoplasms include facial nerve dysfunction and Frey syndrome (also known as gustatory flushing and sweating and auriculotemporal syndrome).[9] Frey syndrome has been successfully treated with injections of botulinum toxin A.[28-30]

Sources: 9 · 28 · 30

Health professional

Treatment Option Overview for Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

The minimum therapy for patients with low-grade malignancies of the superficial portion of the parotid gland is a superficial parotidectomy. For all other lesions, a total parotidectomy is often indicated. The facial nerve or its branches should be resected if involved by tumor; repair can be done simultaneously. Evidence suggests that postoperative radiation therapy augments surgical resection, particularly for the high-grade neoplasms, when margins are close or involved, when tumors are large, or when histological evidence of lymph node metastases is present.[1-8] Clinical trials in the United States and England indicated that fast neutron-beam radiation therapy improves disease-free survival and overall survival in patients with unresectable tumors or for patients with recurrent neoplasms.[9-12] The availability of facilities with fast neutron-beam radiation therapy is limited in the United States. Accelerated hyperfractionated photon-beam radiation therapy has also resulted in high rates of long-term local regional controls.[13,14] The use of chemotherapy for malignant salivary gland tumors remains under evaluation.[15-19]

Sources: 1 · 8 · 9 · 12 · 13 · 14 · 15 · 19

Health professional

Treatment of Stage I Major Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Health professional · Treatment of Stage I Major Salivary Gland Cancer

Treatment Options for Low-Grade Stage I Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for low-grade stage I major salivary gland tumors include:

Surgery alone.

Postoperative radiation therapy should be considered when the resection margins are positive.

Low-grade stage I tumors of the salivary gland are curable with surgery alone.[1-3] Radiation therapy may be used for tumors for which resection involves a significant cosmetic or functional deficit or as an adjuvant to surgery when positive margins are present.[4] Neutron-beam therapy is effective in the treatment of patients with malignant salivary gland tumors who have a poor prognosis.[5-7]

Sources: 1 · 3 · 4 · 5 · 7

Health professional · Treatment of Stage I Major Salivary Gland Cancer

Treatment Options for High-Grade Stage I Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for high-grade stage I major salivary gland tumors include:

Localized high-grade salivary gland tumors that are confined to the gland in which they arise may be cured by radical surgery alone.

Postoperative radiation therapy may improve local control and increase survival rates for patients with high-grade tumors, positive surgical margins, or perineural invasion.[8][Level of evidence C2]; [9-11]

Sources: 8 · Level of evidence C2 · 9 · 11

Chemotherapy (under clinical evaluation).[12,13]

Sources: 12 · 13

Clinical trials exploring newer methods of local control are appropriate.

High-grade stage I salivary gland tumors that are confined to the gland in which they arise may be cured by surgery alone. Adjuvant radiation therapy may be used, especially with the presence of positive margins.

Health professional

Treatment of Stage II Major Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Health professional · Treatment of Stage II Major Salivary Gland Cancer

Treatment Options for Low-Grade Stage II Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for low-grade stage II major salivary gland tumors include:

Surgery alone or with postoperative radiation therapy, if indicated, is appropriate.[1,2]

Sources: 1 · 2

Chemotherapy should be considered in special circumstances, such as when radiation therapy or surgery is refused.

Low-grade stage II tumors of the salivary gland may be cured with surgery alone.[3-5] Radiation therapy may be used as primary treatment for tumors for in which resection involves a significant cosmetic or functional deficit or as an adjuvant to surgery when positive margins are present.[6]

Sources: 3 · 5 · 6

Health professional · Treatment of Stage II Major Salivary Gland Cancer

Treatment Options for High-Grade Stage II Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for high-grade stage II major salivary gland tumors include:

Localized high-grade salivary gland tumors that are confined to the gland in which they arise may be cured by radical surgery alone.

Postoperative radiation therapy may improve local control and increase survival rates for patients with high-grade tumors, positive surgical margins, or perineural invasion.[7][Level of evidence C2]; [8-10]

Sources: 7 · Level of evidence C2 · 8 · 10

Fast neutron-beam radiation therapy or accelerated hyperfractionated photon-beam schedules reportedly are more effective than conventional x-ray therapy in the treatment of patients with inoperable, unresectable, or recurrent malignant salivary gland tumors.[11-14]

Sources: 11 · 14

Chemotherapy (under clinical evaluation).[15,16]

Sources: 15 · 16

Clinical trials exploring ways to improve local control with radiation therapy and/or radiosensitizers are appropriate.

High-grade stage II salivary gland tumors that are confined to the gland in which they arise may be cured by surgery alone, although adjuvant radiation therapy may be used, especially if positive margins are present. Primary radiation therapy may be given for tumors that are inoperable, unresectable, or recurrent. Fast neutron-beam radiation therapy has been shown to improve disease-free survival and overall survival in this clinical situation.[11,13,14]

Sources: 11 · 13 · 14

Health professional

Treatment of Stage III Major Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Health professional · Treatment of Stage III Major Salivary Gland Cancer

Treatment Options for Low-Grade Stage III Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for low-grade stage III major salivary gland tumors include:

Surgery alone or with postoperative radiation therapy, if indicated, is appropriate.

Chemotherapy should be considered in special circumstances, such as when radiation or surgery is refused or when tumors are recurrent or nonresponsive.

Fast neutron-beam radiation therapy (under clinical evaluation). Data on fast neutron-beam radiation therapy have indicated superior results when compared with conventional radiation therapy using x-rays.[1,2]

Sources: 1 · 2

Chemotherapy (under clinical evaluation).[3,4]

Sources: 3 · 4

Patients with low-grade stage III tumors of the salivary gland may be cured with surgery alone.[5-7] Radiation therapy as primary treatment is not often required but may be used for tumors for which resection involves a significant cosmetic or functional deficit, or as an adjuvant to surgery when positive margins are present.[8] Patients with low-grade tumors that have spread to lymph nodes may be cured with resection of the primary tumor and the involved lymph nodes, with or without radiation therapy. Neutron-beam therapy is effective in the treatment of patients with tumors that have spread to local lymph nodes.

Sources: 5 · 7 · 8

Health professional · Treatment of Stage III Major Salivary Gland Cancer

Treatment Options for High-Grade Stage III Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Treatment options for high-grade stage III major salivary gland tumors include:

Patients with localized high-grade salivary gland tumors that are confined to the gland in which they arise may be cured by radical surgery alone.[9,10]

Sources: 9 · 10

Postoperative radiation therapy may improve local control and increase survival rates for patients with high-grade tumors, positive surgical margins, or perineural invasion.[11][Level of evidence C2]; [12-14]

Sources: 11 · Level of evidence C2 · 12 · 14

Fast neutron-beam radiation therapy or accelerated hyperfractionated photon-beam schedules have been reported to be more effective than conventional x-ray therapy in the treatment of patients with inoperable, unresectable, or recurrent malignant salivary gland tumors.[1,15-17]

Sources: 1 · 15 · 17

Radiation therapy, radiosensitizers, and chemotherapy (under clinical evaluation). Clinical trials are exploring ways to improve local control with these modalities.[2-4,18,19]

Sources: 2 · 4 · 18 · 19

Patients with high-grade stage III salivary gland tumors that are confined to the gland in which they arise may be cured by surgery alone, although adjuvant postoperative radiation therapy may be used, especially if positive margins are present. Primary conventional x-ray radiation therapy may provide palliation for patients with unresectable tumors. Fast neutron beams, however, have been reported to improve disease-free survival and overall survival in this clinical situation.[1,16,17] Patients with tumors that have spread to regional lymph nodes should have a regional lymphadenectomy as part of the initial surgical procedure. Adjuvant radiation therapy for these tumors may reduce the local recurrence rate.

Sources: 1 · 16 · 17

Health professional

Treatment of Stage IV Major Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Health professional · Treatment of Stage IV Major Salivary Gland Cancer

Treatment Options for Stage IV Major Salivary Gland Tumors

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

Standard therapy for patients with tumors that have spread to distant sites is not curative.

Treatment options for high-grade stage IV major salivary gland tumors include:

Fast neutron-beam radiation therapy or accelerated hyperfractionated photon-beam schedules have been reported to be more effective than conventional x-ray therapy in the treatment of patients with inoperable, unresectable, or recurrent malignant salivary gland tumors.[1-5]

Sources: 1 · 5

Aggressive combinations of chemotherapy and radiation (under clinical evaluation).

Patients with stage IV salivary gland cancer and patients with any metastatic lesions should consider enrollment in clinical trials. Their cancer may be responsive to aggressive combinations of chemotherapy and radiation. Patients with any metastatic lesions could consider clinical trials. Chemotherapy using doxorubicin, cisplatin, cyclophosphamide, and fluorouracil as single agents or in various combinations is associated with modest response rates.[6-14]

Sources: 6 · 14

Health professional · Treatment of Stage IV Major Salivary Gland Cancer / Treatment Options for Stage IV Major Salivary Gland Tumors

Fluorouracil dosing

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

The DPYD gene encodes an enzyme that catabolizes pyrimidines and fluoropyrimidines, like capecitabine and fluorouracil. An estimated 1% to 2% of the population has germline pathogenic variants in DPYD, which lead to reduced DPD protein function and an accumulation of pyrimidines and fluoropyrimidines in the body.[15,16] Patients with the DPYD*2A variant who receive fluoropyrimidines may experience severe, life-threatening toxicities that are sometimes fatal. Many other DPYD variants have been identified, with a range of clinical effects.[15-17] Fluoropyrimidine avoidance or a dose reduction of 50% may be recommended based on the patient's DPYD genotype and number of functioning DPYD alleles.[18-20] DPYD genetic testing costs less than $200, but insurance coverage varies due to a lack of national guidelines.[21] In addition, testing may delay therapy by 2 weeks, which would not be advisable in urgent situations. This controversial issue requires further evaluation.[22]

Sources: 15 · 16 · 15 · 17 · 18 · 20 · 21 · 22

Health professional

Treatment of Recurrent Major Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 13, 2025. Captured 2026-09-09.

The prognosis for any patient with progressing or relapsing salivary gland cancer is poor, regardless of cell type or stage. Selecting further treatment depends on many factors, including the specific cancer, prior treatment, site of recurrence, and individual patient considerations. Fast neutron-beam radiation therapy is superior to conventional radiation therapy using x-rays and may be curative in selected patients with recurrent disease.[1]

Sources: 1

Patients with inoperable, unresectable, or recurrent malignant salivary gland tumors treated with fast neutron-beam radiation therapy have better disease-free survival and overall survival than patients treated with conventional x-ray radiation therapy.[2-5] Clinical trials are appropriate and should be considered when possible.

Sources: 2 · 5

For patients · General Information About Salivary Gland Cancer

Certain factors affect prognosis (chance of recovery) and treatment options.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

The prognosis and treatment options depend on the following:

Sources: prognosis

The stage of the cancer (especially the size of the tumor).

Sources: stage

The type of salivary gland the cancer is in.

The type of cancer cells (how they look under a microscope).

The patient's age and general health.

For patients · Stages of Salivary Gland Cancer

Salivary gland cancer can recur (come back) after it has been treated.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

The cancer may come back in the salivary glands or in other parts of the body.

For patients

Treatment Option Overview

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For patients · Treatment Option Overview

Key Points

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

There are different types of treatment for patients with salivary gland cancer.

Patients with salivary gland cancer should have their treatment planned by a team of health care providers who are experts in treating head and neck cancer.

The following types of treatment are used:

The following types of treatment are used:

Surgery

Radiation therapy

Chemotherapy

New types of treatment are being tested in clinical trials.

New types of treatment are being tested in clinical trials.

Radiosensitizers

Treatment for salivary gland cancer may cause side effects.

Patients may want to think about taking part in a clinical trial.

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Follow-up tests may be needed.

For patients · Treatment Option Overview

There are different types of treatment for patients with salivary gland cancer.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Different types of treatment are available for patients with salivary gland cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

Sources: standard · clinical trials · research study

For patients · Treatment Option Overview

Patients with salivary gland cancer should have their treatment planned by a team of health care providers who are experts in treating head and neck cancer.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Treatment will be overseen by a medical oncologist, a doctor who specializes in treating cancer. Because the salivary glands help in eating and digesting food, patients may need special help adjusting to the side effects of the cancer and its treatment. The medical oncologist may refer you to other health care providers who have experience and expertise in treating patients with head and neck cancer and who specialize in certain areas of medicine. These may include the following specialists:

Sources: medical oncologist · salivary glands · side effects · health care providers · head and neck cancer · specialists

Head and neck surgeon.

Sources: surgeon

Radiation oncologist.

Sources: Radiation oncologist

Dentist.

Sources: Dentist

Speech therapist.

Sources: Speech therapist

Dietitian.

Sources: Dietitian

Psychologist.

Sources: Psychologist

Rehabilitation specialist.

Sources: Rehabilitation specialist

Plastic surgeon.

Sources: Plastic surgeon

For patients · Treatment Option Overview

The following types of treatment are used:

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For patients · Treatment Option Overview / The following types of treatment are used:

Surgery

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Surgery (removing the cancer in an operation) is a common treatment for salivary gland cancer. A doctor may remove the cancer and some of the healthy tissue around the cancer. In some cases, a lymphadenectomy (surgery in which lymph nodes are removed) will also be done.

Sources: lymphadenectomy · lymph nodes

After the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given radiation therapy after surgery to kill any cancer that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.

Sources: radiation therapy · adjuvant therapy

For patients · Treatment Option Overview / The following types of treatment are used:

Radiation therapy

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing.

Sources: x-rays · radiation

External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.Special types of external radiation may be used to treat some salivary gland tumors. These include:

Sources: External radiation therapy

External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.Special types of external radiation may be used to treat some salivary gland tumors. These include:

Fast-neutron radiation therapy: Fast-neutron radiation therapy is a type of high-energy external radiation therapy. A radiation therapy machine aims neutrons (tiny, invisible particles) at the cancer cells to kill them. Fast-neutron radiation therapy uses a higher-energy radiation than the x-ray type of radiation therapy. This allows the radiation therapy to be given in fewer treatments.

Photon-beam radiation therapy: Photon-beam radiation therapy is a type of external radiation therapy that reaches deep tumors with high-energy x-rays made by a machine called a linear accelerator. This can be delivered as hyperfractionated radiation therapy, in which the total dose of radiation is divided into small doses, and the treatments are given more than once a day.

Sources: linear accelerator · hyperfractionated radiation therapy · dose

External radiation therapy is used to treat salivary gland cancer and may also be used as palliative therapy to relieve symptoms and improve quality of life.

Sources: palliative therapy · symptoms · quality of life

For patients · Treatment Option Overview / The following types of treatment are used:

Chemotherapy

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy).

Sources: injected · systemic chemotherapy

Learn more about Drugs Approved for Head and Neck Cancer. (Salivary gland cancer is a type of head and neck cancer.)

Sources: Drugs Approved for Head and Neck Cancer

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.

Sources: NCI website

For patients · Treatment Option Overview / New types of treatment are being tested in clinical trials.

Radiosensitizers

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Radiosensitizers are drugs that make tumor cells more sensitive to radiation therapy. Combining radiation therapy with radiosensitizers may kill more tumor cells.

Sources: Radiosensitizers

For patients · Treatment Option Overview

Treatment for salivary gland cancer may cause side effects.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about side effects caused by treatment for cancer, visit our Side Effects page.

Sources: side effects · Side Effects

For patients · Treatment Option Overview

Patients may want to think about taking part in a clinical trial.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.

Sources: clinical trial · standard treatment

Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.

Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.

For patients · Treatment Option Overview

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.

Sources: side effects

Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.

Sources: clinical trials search · ClinicalTrials.gov

For patients · Treatment Option Overview

Follow-up tests may be needed.

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.

Sources: diagnose · stage

Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).

For patients

Treatment of Stage I Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment for stage I salivary gland cancer depends on whether the cancer is low-grade (slow growing) or high-grade (fast growing).

Sources: stage I salivary gland cancer · low-grade · high-grade

If the cancer is low-grade, treatment may include the following:

Surgery with or without radiation therapy.

Sources: radiation therapy

Fast-neutron radiation therapy.

Sources: Fast-neutron radiation therapy

If the cancer is high-grade, treatment may include the following:

Surgery with or without radiation therapy.

A clinical trial of chemotherapy.

Sources: clinical trial · chemotherapy

A clinical trial of a new local therapy.

Sources: local therapy

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Stage II Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment for stage II salivary gland cancer depends on whether the cancer is low-grade (slow growing) or high-grade (fast growing).

Sources: stage II salivary gland cancer · low-grade · high-grade

If the cancer is low-grade, treatment may include the following:

Surgery with or without radiation therapy.

Sources: radiation therapy

Radiation therapy.

Chemotherapy.

Sources: Chemotherapy

If the cancer is high-grade, treatment may include the following:

Surgery with or without radiation therapy.

Fast-neutron or photon-beam radiation therapy.

Sources: Fast-neutron · photon-beam radiation therapy

A clinical trial of chemotherapy.

A clinical trial of radiation therapy and/or radiosensitizers.

Sources: clinical trial · radiosensitizers

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Stage III Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment for stage III salivary gland cancer depends on whether the cancer is low-grade (slow growing) or high-grade (fast growing).

Sources: stage III salivary gland cancer · low-grade · high-grade

If the cancer is low-grade, treatment may include the following:

Surgery with or without lymphadenectomy. Radiation therapy may also be given after surgery.

Sources: lymphadenectomy · Radiation therapy

Radiation therapy.

Fast-neutron radiation therapy to lymph nodes with cancer.

Sources: Fast-neutron radiation therapy · lymph nodes

Chemotherapy.

Sources: Chemotherapy

A clinical trial of fast-neutron radiation therapy to the tumor.

Sources: clinical trial

A clinical trial of chemotherapy.

If the cancer is high-grade, treatment may include the following:

Surgery with or without lymphadenectomy. Radiation therapy may also be given after surgery.

Fast-neutron radiation therapy.

Radiation therapy as palliative therapy to relieve symptoms and improve quality of life.

Sources: palliative therapy · symptoms · quality of life

A clinical trial of radiation therapy and/or radiosensitizers.

Sources: radiosensitizers

A clinical trial of chemotherapy.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Stages IVA, IVB, and IVC Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment of stage IVA, stage IVB, and stage IVC salivary gland cancer may include the following:

Sources: stage IVA · stage IVB · stage IVC salivary gland cancer

Fast-neutron or photon-beam radiation therapy.

Sources: Fast-neutron · photon-beam radiation therapy

A clinical trial of chemotherapy with or without radiation therapy.

Sources: clinical trial · chemotherapy · radiation therapy

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Recurrent Salivary Gland Cancer

Source: Salivary Gland Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 14, 2025. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment of recurrent salivary gland cancer may include the following:

Sources: recurrent

Radiation therapy.

Sources: Radiation therapy

A clinical trial of a new treatment.

Sources: clinical trial

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

Studies

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

NCT00095563 · COMPLETED · phase2

High-grade Salivary Gland Carcinoma, High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma,...

ClinicalTrials.gov record

Iressa Study in Patients With Salivary Gland Cancer

NCT00509002 · COMPLETED · phase2

Salivary Gland Cancer

ClinicalTrials.gov record

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

NCT00859937 · COMPLETED · phase2

Malignant Salivary Gland Neoplasm, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v7

ClinicalTrials.gov record

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

NCT01175980 · COMPLETED · phase2

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage III Major Salivary Gland Cancer AJCC v7,...

ClinicalTrials.gov record

Stereotactic Body Radiotherapy for Head and Neck Tumors

NCT01344356 · COMPLETED · phase4

Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Salivary Gland Cancer, Head and Neck Sarcoma, Paraganglioma of Head and Neck, Chordoma of Head and Neck,...

ClinicalTrials.gov record

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

NCT01604772 · COMPLETED · phase2

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage IVA Major Salivary Gland Cancer AJCC v7,...

ClinicalTrials.gov record

Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

NCT01613768 · COMPLETED · phase2

Recurrent Salivary Gland Cancer, Stage IVA Salivary Gland Cancer, Stage IVB Salivary Gland Cancer, Stage IVC Salivary Gland Cancer

ClinicalTrials.gov record

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

NCT02749903 · ACTIVE NOT RECRUITING · phase2

Androgen Receptor Positive, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Salivary Duct Carcinoma, Salivary Gland Adenocarcinoma, NOS,...

ClinicalTrials.gov record

Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

NCT03146650 · UNKNOWN · phase2

Major Salivary Gland Carcinoma, Minor Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Carcinoma, Stage IVA Major Salivary Gland...

ClinicalTrials.gov record

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

NCT03172624 · COMPLETED · phase2

Salivary Gland Cancer

ClinicalTrials.gov record

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

NCT03749460 · COMPLETED · phase1, phase2

Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung, Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8, Stage IVA Major...

ClinicalTrials.gov record

A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma

NCT04325828 · ACTIVE NOT RECRUITING · phase2

Salivary Gland Neoplasms

ClinicalTrials.gov record

A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

NCT04639219 · ACTIVE NOT RECRUITING · phase2

Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast

ClinicalTrials.gov record

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

NCT04895735 · ACTIVE NOT RECRUITING · phase2

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8, Adenoid Cystic Carcinoma

ClinicalTrials.gov record

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

NCT05010629 · ACTIVE NOT RECRUITING · phase2

Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer, Adenoid Cystic Carcinoma

ClinicalTrials.gov record

Amivantamab in Adenoid Cystic Carcinoma

NCT05074940 · ACTIVE NOT RECRUITING · phase2

Salivary Gland Cancer

ClinicalTrials.gov record

Disease and treatment settings

Adenoid Cystic Carcinoma

Disease and treatment setting

Adenoid Cystic Carcinoma

recurrent Salivary Gland Cancer

Disease and treatment setting

Treatment of Recurrent Major Salivary Gland Cancer

Salivary Gland Cancer

Disease and treatment setting

Salivary Gland Cancer

Stage I Salivary Gland Cancer

Disease and treatment setting

Treatment of Stage I Major Salivary Gland Cancer

Stage II Salivary Gland Cancer

Disease and treatment setting

Treatment of Stage II Major Salivary Gland Cancer

Stage III Salivary Gland Cancer

Disease and treatment setting

Treatment of Stage III Major Salivary Gland Cancer

Stage IV Salivary Gland Cancer

Disease and treatment setting

Treatment of Stage IV Major Salivary Gland Cancer

Stage IVC Major Salivary Gland Cancer AJCC v7

Disease and treatment setting

Stage IVC Major Salivary Gland Cancer AJCC v7

Stage IVC Major Salivary Gland Cancer AJCC v8

Disease and treatment setting

Stage IVC Major Salivary Gland Cancer AJCC v8

Drug labels

Pilocarpine hydrochloride

Label date 2026-01-23

INDICATIONS AND USAGE Pilocarpine Hydrochloride Tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of...

DailyMed label

Pilocarpine hydrochloride

Label date 2021-08-31

INDICATIONS AND USAGE Pilocarpine Hydrochloride Tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of...

DailyMed label

Salagen

Label date 2024-12-05

INDICATIONS & USAGE SALAGEN ® Tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in...

DailyMed label